Advertisement

Journal of Artificial Organs

, Volume 2, Issue 2, pp 157–162 | Cite as

Improved hemostasis with the combination of a heparin-coated circuit and aprotinin prime during open-heart surgery: potentiating effect on platelet preservation

  • Kazuhiro Hashimoto
  • Tatsuumi Sasaki
  • Takashi Hachiya
  • Katsuhisa Onoguchi
  • Hiromitsu Takakura
  • Ryuichi Nagahori
  • Motohiro Oshiumi
  • Sigeyuki Takeuchi
Original Article

Abstract

Aprotinin administration with or without a heparin-coated circuit is expected to modulate subclinical plasma coagulation and fibrinolysis and platelet function during cardiopulmonary bypass. We studied the effect of the application of both, either one, or neither of an aprotinin prime (100 million KIU) and heparin-coated circuit in 32 consecutive patients undergoing coronary artery bypass surgery randomly divided into four groups of 8 patients each. Aprotinin was not used with the non-heparin-coated circuit in the control group. Levels of fibrinopeptide A were significantly lower in the heparin-coated circuit groups (P<0.05–0.01), irrespective of an aprotinin prime. D-dimer levels in the control group were significantly higher than in the other groups (P<0.05–0.01). The preservation rates of platelet count and function (acceleration of coagulation by platelet activating factor) in the control group were significantly lower than in the other three groups (P<0.05–0.01). Platelet preservation in the aprotinin plus heparin-coated group was significantly better than in the aprotinin only and the heparin-coated only groups (P<0.05). The amount of mediastinal drainage and the units of blood transfusion were significantly reduced in the two aprotinin groups, irrespective of heparin-coated use (P<0.01). The values in the aprotinin plus heparin-coated group were significantly less than the values in the heparin-coated only group (P<0.05). The heparin-coated circuit was beneficial for suppressing subclinical plasma coagulation and fibrinolysis and for preserving platelets. Addition of the minimal-dose aprotinin prime further preserved about a further reduction in postoperative blood loss and blood requirements.

Key words

Hearin-coated Cardiopulmonary bypass Aprotinin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975;70:76–85.PubMedGoogle Scholar
  2. 2.
    Moriau M, Masure R, Hurlet A, Debeys C, Chalant C, Ponlot R, Jaumain P, Servaye-Kestens, Ravaux A, Louis A, Goenen M. Hemostasis disorders in open heart surgery with extracorporeal circulation. Vox Sang 1977;32:41–51PubMedCrossRefGoogle Scholar
  3. 3.
    Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986;314:1446–1448PubMedCrossRefGoogle Scholar
  4. 4.
    George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991;324:27–39PubMedCrossRefGoogle Scholar
  5. 5.
    Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaard-Hunsen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:958–967PubMedGoogle Scholar
  6. 6.
    Fuhrer G, Gallimore W, Heller W, Hoffmeister H-E. Aprotinin in cardiopulmonary bypass-effect on the Hageman factor (FXII)— kallikrein system and blood loss. Blood Coagul Fibrinolysis 1992;3:99–104PubMedGoogle Scholar
  7. 7.
    Mohr R, Goor DA, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study. Circulation 1992;86(suppl II):II-405–II-409Google Scholar
  8. 8.
    Kawasuji M, Uemura K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. Ann Thorac Surg 1993;55:1205–1209PubMedCrossRefGoogle Scholar
  9. 9.
    Lavee J, Raviv Z, Smolinsky A, Savion N, Varon D, Goor DA, Mohr R. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. Ann Thorac Surg 1993; 55:114–119PubMedCrossRefGoogle Scholar
  10. 10.
    Liu B, Tengborn L, Larson G, Radberg LOG, Belboul A, Dernevik L, Roberts D. Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operations. Ann Thorac Surg 1995;59:1534–1540PubMedCrossRefGoogle Scholar
  11. 11.
    Hayashida N, Isomura T, Sato T, Maruyama H, Kosuga K, Aoyag S. Effect of minimal-dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997;114:261–269PubMedCrossRefGoogle Scholar
  12. 12.
    Videm V, Svennevig JL, Fosse F, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992;103:806–813PubMedGoogle Scholar
  13. 13.
    Borowiec J, Thelin S, Bagge L, Nillson L, Venge P, Hansson HE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992;104:642–647PubMedGoogle Scholar
  14. 14.
    Pekna M, Hagman L, Halden E, Nilsson UR, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg 1994;58:421–424PubMedCrossRefGoogle Scholar
  15. 15.
    Fosse F, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994;58:472–477PubMedCrossRefGoogle Scholar
  16. 16.
    Jansen PGM, te Velthuis H, Huybregts RAJM, Paulus R, Bulder ER, van der Spoel HI, Bezemer PD, Slaats Ed H, Eijsman L, Wildevuur CRH. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg 1995;110:829–834PubMedCrossRefGoogle Scholar
  17. 17.
    Jansen PGM, Baufreton C, Besnerais PL, Loisance DY, Wildevuur CRH. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 1996;61:1363–1366PubMedCrossRefGoogle Scholar
  18. 18.
    Despotis GJ, Levine V, Filos KS, Santoro SA, Joist JH, Spitznagel E, Goodnough LT. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 1996;85:1311–1323PubMedCrossRefGoogle Scholar
  19. 19.
    Jobes DR, Schwartz AJ, Ellison N, Andrews R, Ruffini RA, Ruffini JJ. Monitoring heparin anticoagulation and its neutralization. Ann Thorac Surg 1981;31:161–166PubMedCrossRefGoogle Scholar
  20. 20.
    Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, Cox JL, Lappas DG. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994;108:1076–1082PubMedGoogle Scholar
  21. 22.
    Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC (eds) Surgery of the chest, Philadelphia: Saunders, 1990;1107–1125Google Scholar
  22. 23.
    Gu YJ, van Oeveren W, van der Kamp KWHJ, Akkerman C, Boonstra PW, Wilderevuur CRH. Heparin coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991;6:220–225Google Scholar
  23. 24.
    Pasche B, Kodama K, Larm O, Olsson P, Swedenborg J. Thrombin inactivation on surfaces with covalently bonded heparin. Thromb Res 1986;44:739–748PubMedCrossRefGoogle Scholar
  24. 25.
    Gorman RC, Ziats NP, Rao AK, Gikakis N, Sun L, Khan MMH, Stenach N, Sapatnekar S, Chouhan V, Gorman JH, Niewiarowski S, Colman RW, Anderson JM, Edmunds LH. Surface-bonded heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:1–12.PubMedCrossRefGoogle Scholar
  25. 26.
    Shiiya N, Ikeda H, Matsuzaki K, Watanabe M, Matsui Y, Sekiguchi S, Yasuda K. Does a heparin-coated cardiopulmonary bypass circuit favorably affect hemostatic function? (in Japanese with English abstract). Jpn J Artif Organs 1998;27:418–422Google Scholar
  26. 27.
    Bannan S, Mortin PG. Thrombin generation with heparin-bonded cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 1996; 112:849PubMedGoogle Scholar
  27. 28.
    de Haan J, Boonstra PW, Tabuchi N, van Oeveren W, Ebels T. Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit. J Thorac Cardiovasc Surg 1996;111:272–275PubMedCrossRefGoogle Scholar
  28. 29.
    Chung JH, Gikakis N, Rao K, Drake TA, Colman RW, Edmunds H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996;93:2014–2018PubMedGoogle Scholar
  29. 30.
    von Segesser LK, Weiss BM, Pasic M, Garcia E, Turina MI. Risk and benefit of low systemic heparinization during open-heart operations. Ann Thorac Surg 1994;58:391–398CrossRefGoogle Scholar
  30. 31.
    Boosstra PW, Gu YJ, Akkerman C, Haan J, Huyzen R, von Oeveren W. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:289–292Google Scholar
  31. 32.
    Green D, Sanders J, Eiken M, Wong CA, Frederiksen J, Joob A, Palmer A, Trowbridge A, Woodruff B, Moerch M, Tabanera R, Edsberg B. Recombinant aprotinin in coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1995;110:963–970PubMedCrossRefGoogle Scholar
  32. 33.
    van der Meer J, Hillege HL, Ascoop CAP, Dunselman PHJ, Mulder BJM, van Ommen GVA, Pfisterer M, von Gilst WH, Lie KI. Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study. Thromb Haemost 1996;75:1–3PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 1999

Authors and Affiliations

  • Kazuhiro Hashimoto
    • 1
  • Tatsuumi Sasaki
    • 1
  • Takashi Hachiya
    • 1
  • Katsuhisa Onoguchi
    • 1
  • Hiromitsu Takakura
    • 1
  • Ryuichi Nagahori
    • 1
  • Motohiro Oshiumi
    • 1
  • Sigeyuki Takeuchi
    • 1
  1. 1.Department of Cardiovascular SurgerySaltama Cardiovascular and Respiratory CenterSaitamaJapan

Personalised recommendations